Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.
2.

Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.

Katz LJ, Simmons ST, Craven ER.

Curr Med Res Opin. 2007 Dec;23(12):2971-83. Review.

PMID:
17949534
3.

Intraocular pressure-lowering combination therapies with prostaglandin analogues.

Aptel F, Chiquet C, Romanet JP.

Drugs. 2012 Jul 9;72(10):1355-71. doi: 10.2165/11634460-000000000-00000. Review.

PMID:
22686588
4.

Fixed combinations of topical glaucoma medications.

Fechtner RD, Realini T.

Curr Opin Ophthalmol. 2004 Apr;15(2):132-5. Review.

PMID:
15021225
5.

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus.

Nguyen QH.

Patient Prefer Adherence. 2014 Jun 12;8:853-64. doi: 10.2147/PPA.S53162. eCollection 2014. Review.

6.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627
7.

Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.

Ormrod D, McClellan K.

Drugs Aging. 2000 Dec;17(6):477-96. Review.

PMID:
11200308
8.

Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.

Holló G, Bozkurt B, Irkec M.

Expert Opin Pharmacother. 2009 Aug;10(12):2015-24. doi: 10.1517/14656560903124388. Review.

PMID:
19618994
9.

Use of fixed-dose combination drugs for the treatment of glaucoma.

Khouri AS, Realini T, Fechtner RD.

Drugs Aging. 2007;24(12):1007-16. Review.

PMID:
18020533
10.

The efficacy and safety of unfixed and fixed combinations of latanoprost and other antiglaucoma medications.

Higginbotham EJ, Diestelhorst M, Pfeiffer N, Rouland JF, Alm A.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S133-40. Review.

PMID:
12204710
11.

Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma.

Aptel F, Denis P.

Curr Med Res Opin. 2011 Oct;27(10):1949-58. doi: 10.1185/03007995.2011.613923. Epub 2011 Aug 31. Review.

PMID:
21878000
12.

Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice.

Holló G, Topouzis F, Fechtner RD.

Expert Opin Pharmacother. 2014 Aug;15(12):1737-47. doi: 10.1517/14656566.2014.936850. Epub 2014 Jul 5. Review.

PMID:
24998246
13.
14.
15.

[Fixed combinations of glaucoma medications].

Călugăru D, Călugăru M.

Oftalmologia. 2008;52(3):23-31. Review. Romanian.

PMID:
19149113
16.

Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.

Diestelhorst M, Nordmann JP, Toris CB.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S155-61. Review.

PMID:
12204713
17.

Update on the role of alpha-agonists in glaucoma management.

Arthur S, Cantor LB.

Exp Eye Res. 2011 Sep;93(3):271-83. doi: 10.1016/j.exer.2011.04.002. Epub 2011 Apr 20. Review.

PMID:
21524649
19.
20.

The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies.

Radcliffe NM.

Clin Ophthalmol. 2014 Dec 12;8:2541-9. doi: 10.2147/OPTH.S76053. eCollection 2014. Review.

Supplemental Content

Support Center